Page 3 - Sumit Chanda News Today

Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a low-dose, oral COVID antiviral drug that can be administered at home.

The multidisciplinary center will focus on the development of antiviral drugs to combat coronaviruses and other viruses with pandemic potential.

A major new antiviral drug development center led by Scripps Research in La Jolla to prime for the next pandemic is getting a $67 million award over three years from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, with potential renewal for two additional years.

The La Jolla institute's partners will include its drug development init Calibr, and UC San Diego

The La Jolla institute's partners will include its drug development init Calibr, and UC San Diego

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

Telangana IT and MAUD KT Rama Rao, visited the Scripps Research Campus today and met the institute’s leadership Dr. James Williamson, EVP Research and Academic Affairs, Ms. Mary Wang, Director, Strategic Planning, Dr. Arnab Chatterjee, VP, Medicinal Chemistry, Calibr-Scripps Research and Prof. Sumit Chanda.

Chemveda Life Sciences has announced a Rs 150 crore investment to expand its presence in Hyderabad.

Beyond COVID-19: Preparing for future pandemic threats - Front Row lecture with Sumit Chanda, PhDOne thing that the COVID-19 pandemic laid clear is that when—not if—the next pandemic occurs, humanity needs to be much better prepared. In his Front Row lecture, leading infectious disease researcher Sumit Chanda, PhD, will share his research on how pathogens infect cells and how the immune system responds. He will talk about his team's efforts against the SARS-CoV-2, the cause of COVID ill...

The La Jolla Light presents this continuing series of online activities to undertake on your computer or tablet, as well as local in-person events. • The La Jolla Community Center presents “Build a Better Brain” at 10 a.m.